DE2243961C2 - - Google Patents
Info
- Publication number
- DE2243961C2 DE2243961C2 DE2243961A DE2243961A DE2243961C2 DE 2243961 C2 DE2243961 C2 DE 2243961C2 DE 2243961 A DE2243961 A DE 2243961A DE 2243961 A DE2243961 A DE 2243961A DE 2243961 C2 DE2243961 C2 DE 2243961C2
- Authority
- DE
- Germany
- Prior art keywords
- compound
- general formula
- acid
- ether
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/36—Compounds containing oxirane rings with hydrocarbon radicals, substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/16—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/587—Unsaturated compounds containing a keto groups being part of a ring
- C07C49/753—Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/22—Bridged ring systems
- C07D221/28—Morphinans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/26—Phenanthrenes; Hydrogenated phenanthrenes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17883771A | 1971-09-08 | 1971-09-08 | |
| US00217633A US3819635A (en) | 1971-09-08 | 1972-01-13 | 14-hydroxymorphinan derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2243961A1 DE2243961A1 (de) | 1973-04-05 |
| DE2243961C2 true DE2243961C2 (US06252093-20010626-C00008.png) | 1988-07-21 |
Family
ID=26874723
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2265255A Expired DE2265255C2 (de) | 1971-09-08 | 1972-09-07 | 2-Aminoäthylhexahydrophenanthren-Derivate und deren Säureadditionssalze |
| DE2265256A Expired DE2265256C2 (de) | 1971-09-08 | 1972-09-07 | Morphinanderivate und Verfahren zu deren Herstellung |
| DE2243961A Granted DE2243961A1 (de) | 1971-09-08 | 1972-09-07 | Verfahren zur herstellung von analgetischen verbindungen |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE2265255A Expired DE2265255C2 (de) | 1971-09-08 | 1972-09-07 | 2-Aminoäthylhexahydrophenanthren-Derivate und deren Säureadditionssalze |
| DE2265256A Expired DE2265256C2 (de) | 1971-09-08 | 1972-09-07 | Morphinanderivate und Verfahren zu deren Herstellung |
Country Status (19)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3910920A (en) * | 1973-11-07 | 1975-10-07 | Bristol Myers Co | 3,14,17-Substituted-6,7-tetramethylenemorphinans |
| US3980641A (en) * | 1975-07-31 | 1976-09-14 | Bristol-Myers Company | Process for the preparation of 14-hydroxymorphinans |
| US4017497A (en) * | 1975-11-18 | 1977-04-12 | Bristol-Myers Company | Process for the preparation of 14-hydroxymorphinan derivatives |
| US4139534A (en) * | 1977-02-17 | 1979-02-13 | Bristol-Myers Company | Process for the preparation of 14-hydroxymorphinan derivatives |
| US4058531A (en) * | 1976-03-23 | 1977-11-15 | Bristol-Myers Company | Process for the preparation of 14-hydroxymorphinan derivatives |
| US4052389A (en) * | 1976-03-23 | 1977-10-04 | Bristol-Myers Company | Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one |
| JPS52136176A (en) * | 1976-03-23 | 1977-11-14 | Bristol Myers Co | Method of improving 144hydroxymorphinan derivatives |
| GB1593191A (en) * | 1977-03-23 | 1981-07-15 | Reckitt & Colmann Prod Ltd | Derivatives of morphine |
| GB1587831A (en) * | 1977-03-23 | 1981-04-08 | Reckitt & Colmann Prod Ltd | Morphine derivatives |
| US4115389A (en) * | 1977-05-02 | 1978-09-19 | Bristol-Myers Company | Process of N-demethylating (-)-1-(p-methoxybenzyl)-2-methyl-1,2,3,4,5,6,7,8-octahydroisoquinoline |
| US4338320A (en) * | 1978-11-15 | 1982-07-06 | The Board Of Regents Of The University Of Nebraska | Esters of 6'-hydroxycinchonine, and a method of treating arrythmia with them |
| US4228285A (en) * | 1979-02-28 | 1980-10-14 | Bristol-Myers Company | 14-Hydroxy-6-oxamorphinans and 14-hydroxy-6-oxaisomorphinans |
| US4272540A (en) * | 1979-04-24 | 1981-06-09 | Sisa, Incorporated | 14-Methoxymorphinan-6-one compounds and therapeutic methods of treating pain and drug dependence with them |
| US4322427A (en) * | 1981-04-16 | 1982-03-30 | Bristol-Myers Company | Analgetic compositions and methods of use |
| DE69414085T2 (de) * | 1993-07-19 | 1999-03-18 | Toray Industries, Inc., Tokio/Tokyo | Wirkstoff zum schutze von gehirnzellen |
| WO1995003308A1 (en) * | 1993-07-23 | 1995-02-02 | Toray Industries, Inc. | Morphinan derivative and medicinal use |
| CZ281174B6 (cs) * | 1993-08-13 | 1996-07-17 | Galena, A.S. | Způsob přípravy 3,14ß-dihydroxy-17-normorfinanu |
| CA2321924A1 (en) | 1998-02-25 | 1999-09-02 | Abbott Laboratories | Butorphanol sustained release formulations |
| US20040167164A1 (en) * | 1998-05-05 | 2004-08-26 | Jose Pozuelo | Compositions and methods for treating particular chemical addictions and mental illnesses |
| US7923454B2 (en) | 2002-05-17 | 2011-04-12 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| US7501433B2 (en) * | 2002-05-17 | 2009-03-10 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| EP1506174B1 (en) | 2002-05-17 | 2015-09-30 | Taiwanj Pharmaceuticals Co., Ltd. | Use of naltrexone for treating kidney and liver damage |
| US8017622B2 (en) * | 2003-05-16 | 2011-09-13 | Jenken Biosciences, Inc. | Opioid and opioid-like compounds and uses thereof |
| CN103073496B (zh) * | 2013-02-18 | 2015-08-26 | 苏州立新制药有限公司 | 右美沙芬的制备方法 |
| JP6464181B2 (ja) | 2014-10-14 | 2019-02-06 | 久光製薬株式会社 | 貼付剤 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3166559A (en) * | 1965-01-19 | J-lower alkoxy-x-phenyloxy-ix-hydroxy- | ||
| GB1028407A (en) * | 1962-04-06 | 1966-05-04 | Shionogi & Co | Improvements in or relating to morphinan derivatives and their preparation |
| FR1362540A (fr) * | 1963-04-05 | 1964-06-05 | Shionogi & Co | Dérivés n substitués du morphinane et leur production |
-
0
- BE BE788478D patent/BE788478A/xx not_active IP Right Cessation
-
1972
- 1972-01-13 US US00217633A patent/US3819635A/en not_active Expired - Lifetime
- 1972-08-23 CA CA150,036A patent/CA999578A/en not_active Expired
- 1972-09-01 AU AU46228/72A patent/AU470102B2/en not_active Expired
- 1972-09-06 IE IE1213/72A patent/IE36687B1/xx unknown
- 1972-09-06 SE SE7211522A patent/SE398877B/xx unknown
- 1972-09-06 IE IE103/76A patent/IE36688B1/xx unknown
- 1972-09-06 DK DK440172AA patent/DK141624B/da not_active IP Right Cessation
- 1972-09-07 GB GB4161972A patent/GB1412129A/en not_active Expired
- 1972-09-07 FR FR7231816A patent/FR2154481B1/fr not_active Expired
- 1972-09-07 DE DE2265255A patent/DE2265255C2/de not_active Expired
- 1972-09-07 DE DE2265256A patent/DE2265256C2/de not_active Expired
- 1972-09-07 CH CH1315472A patent/CH590845A5/xx not_active IP Right Cessation
- 1972-09-07 DE DE2243961A patent/DE2243961A1/de active Granted
- 1972-09-07 NL NL7212176.A patent/NL162072C/xx not_active IP Right Cessation
- 1972-09-07 GB GB1057175A patent/GB1412130A/en not_active Expired
- 1972-09-07 CY CY980A patent/CY980A/xx unknown
- 1972-09-07 YU YU227772A patent/YU45099B/sh unknown
- 1972-09-07 JP JP8916172A patent/JPS5310596B2/ja not_active Expired
- 1972-09-08 DD DD165557A patent/DD100255A5/xx unknown
-
1975
- 1975-06-02 SE SE7506292A patent/SE403286B/xx not_active IP Right Cessation
-
1978
- 1978-12-24 KE KE2911A patent/KE2911A/xx unknown
-
1979
- 1979-01-11 HK HK26/79A patent/HK2679A/xx unknown
- 1979-12-30 MY MY27/79A patent/MY7900027A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2243961C2 (US06252093-20010626-C00008.png) | ||
| DE2614406C2 (US06252093-20010626-C00008.png) | ||
| DE69612003T2 (de) | Substituierte benzolaktamverbindungen als substanz-p-antagonisten | |
| DE2345064C3 (de) | 4-Amino-2-<l,2r3,4-tetrahydroisochinolin-2 yl)-chinazolinderivate und diese enthaltende Arzneimittel | |
| DE2828039A1 (de) | 2-(2-alkoxyethyl)-2'-hydroxy-6,7-benzomorphane deren saeureadditionssalze diese enthaltende arzneimittel und verfahren zu deren herstellung | |
| CH625787A5 (US06252093-20010626-C00008.png) | ||
| DE2027077A1 (de) | 6,7-Benzomorphane, Verfahren zu ihrer Herstellung und ihre Verwendung | |
| DE2002840A1 (de) | 2,3,5-trisubstit,-2'-Hydroxy-6,7-benzomorphane und Verfahren zu deren Herstellung | |
| DE2108954A1 (en) | 2-(furylmethyl)-6,7-benzomorphans - useful as cns active agents | |
| DE3002367A1 (de) | 2-substituierte trans-5-aryl-2,3,4,4a,5, 9b-hexahydro-1h-pyrido eckige klammer auf 4,3-b eckige klammer zu indole | |
| DE2434687A1 (de) | Neue analgetika und verfahren zu ihrer herstellung | |
| EP0064685A1 (de) | Dibenzo(de,g)chinolin-Derivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE1695416A1 (de) | Benzomorphan-derivate und Verfahren zu deren Herstellung | |
| DE2649172C2 (US06252093-20010626-C00008.png) | ||
| DD141156A5 (de) | Verfahren zur herstellung von 4a-aryl-octahydro-1h-2-pyrindinen | |
| CH623039A5 (US06252093-20010626-C00008.png) | ||
| AT395852B (de) | Imidazolyl-methyl-tetrahydrothiophenderivate | |
| CH630903A5 (en) | Process for preparing novel derivatives of 1,2,3,4,4a,10b-hexahydrobenzo(f)isoquinoline. | |
| DE2311881A1 (de) | Morphinanderivate | |
| DE2229770A1 (de) | N-(heteroarylmethyl)-7alpha-acyl6,14-endoaethenotetrahydro-nororipavine und -thebaine, deren hydrierungsprodukte und saeureadditionssalze sowie verfahren zu deren herstellung | |
| CH616143A5 (US06252093-20010626-C00008.png) | ||
| DE1568104B2 (de) | Tricyclische n-alkylierte derivate des acetamids und verfahren zu ihrer herstellung | |
| AT313889B (de) | Verfahren zur Herstellung von neuen 2-(Furyl-methyl)-6,7-benzomorphanderivaten und deren Säureadditionssalzen | |
| CH638519A5 (de) | 2'-hydroxy-2-(5-isoxazolylmethyl)-6,7-benzomorphane, deren saeureadditionssalze und diese verbindungen enthaltende arzneimittel. | |
| AT262288B (de) | Verfahren zur Herstellung von neuen 1-Cycloalkenylpiperidinen sowie von deren Säureadditionssalzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OI | Miscellaneous see part 1 | ||
| AH | Division in |
Ref country code: DE Ref document number: 2265256 Format of ref document f/p: P |
|
| AH | Division in |
Ref country code: DE Ref document number: 2265255 Format of ref document f/p: P |
|
| AH | Division in |
Ref country code: DE Ref document number: 2265256 Format of ref document f/p: P Ref country code: DE Ref document number: 2265255 Format of ref document f/p: P |
|
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition |